PPBP and metabolic dysfunction-associated steatotic liver disease: One targeted proteomics study using extracellular vesicles highlights that levels of APCS and pro-platelet basic protein were significantly decreased in liver fibrosis progression, patients with liver cirrhosis, acute hepatitis and non-alcoholic fatty liver disease patients39.